Global, regional, and national burden of leukemia: Epidemiological trends analysis from 1990 to 2021
PLOS One · 2025
DOI: 10.1371/journal.pone.0325937 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Chengjun Hu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The Affiliated Jiangyin Hospital of Nantong University, Jiangyin, Jiangsu 214400, China. Hauptthemen laut MEDLINE: Leukemia. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Anhui Province School Nature Research Key Project, Anhui Province Teaching Research Program, Wuxi Municipal Health Commission Project.
Abstract (Originalsprache)
Background
Leukemia is a prevalent form of cancer that encompasses four primary subtypes, posing significant health risks. Gaining insights into the global epidemiology of leukemia and its subtypes is crucial for effective resource allocation, clinical guidance, and scientific inquiry.
Methods
From 1990 to 2021, we analyzed age-standardized rates (ASR) trends across 204 countries and territories, utilizing the estimated annual percentage change (EAPC).
Results
In 2021, there were approximately 460,000 leukemia cases, 320,000 deaths, and 10.98 million disability-adjusted life years (DALYs). Globally, age-standardized incidence rates (ASIR), mortality rates (ASMR), and DALY rates are on the decline, while age-standardized prevalence rates (ASPR) are rising in high social demographic index (SDI) regions. Men experience a higher leukemia burden compared to women. By subtype, acute myeloid leukemia (AML), chronic myeloid leukemia (CML), and chronic lymphocytic leukemia (CLL) predominantly impact older individuals, while acute lymphoblastic leukemia (ALL) primarily affects children. Notably, leukemia ASIR and ASDR reductions are observed in countries with high human development index (HDI).
Conclusion
Although there has been a marked decrease in global leukemia incidence, mortality, and DALYs over the past 31 years, the rise in new cases due to population growth suggests an increasing overall disease burden by 2050. Furthermore, the impact of leukemia varies significantly by region and country, highlighting the urgent need for innovative and personalized prevention and treatment approaches to mitigate this global health issue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Hematology, The Affiliated Jiangyin Hospital of Nantong University, Jiangyin, Jiangsu 214400, China.
- School of Information Engineering, Anhui University of Chinese Medicine, Hefei, Anhui 230012, China.
ORCID-Profile: Tongping Shen
Förderung
- the Anhui Province School Nature Research Key Project
- Anhui Province Teaching Research Program
- Wuxi Municipal Health Commission Project
Zitieren
APA
Hu, C., Chen, W., Zhang, P., Shen, T., & Xu, M. (2025). Global, regional, and national burden of leukemia: Epidemiological trends analysis from 1990 to 2021. PLOS One. https://doi.org/10.1371/journal.pone.0325937
Vancouver
Hu C, Chen W, Zhang P, Shen T, Xu M. Global, regional, and national burden of leukemia: Epidemiological trends analysis from 1990 to 2021. PLOS One. 2025. doi:10.1371/journal.pone.0325937
BibTeX
@article{Hu2025,
author = {Hu, Chengjun and Chen, Weifeng and Zhang, Ping and Shen, Tongping and Xu, Maozhong},
title = {Global, regional, and national burden of leukemia: Epidemiological trends analysis from 1990 to 2021},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0325937}
}
EUVIMED